von Ofen A, Thiel U, Eck J, Gassmann H, Thiede M, Hauer J
Front Oncol. 2024; 14:1304374.
PMID: 38357194
PMC: 10865101.
DOI: 10.3389/fonc.2024.1304374.
Dinh N, Nguyen T, Park M, Lee C
Int J Mol Sci. 2024; 25(2).
PMID: 38255791
PMC: 10815159.
DOI: 10.3390/ijms25020717.
Bertzbach L, Seddar L, von Stromberg K, Ip W, Dobner T, Hidalgo P
J Virol. 2024; 98(2):e0188523.
PMID: 38197632
PMC: 10878046.
DOI: 10.1128/jvi.01885-23.
El-Ayoubi A, Arakelyan A, Klawitter M, Merk L, Hakobyan S, Gonzalez-Menendez I
Mol Oncol. 2023; 18(3):528-546.
PMID: 38115217
PMC: 10920084.
DOI: 10.1002/1878-0261.13569.
Ehrenfeld M, Segeth F, Mantwill K, Brockhaus C, Zhao Y, Ploner C
J Virol. 2023; 97(6):e0037023.
PMID: 37219458
PMC: 10308897.
DOI: 10.1128/jvi.00370-23.
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus.
Koch J, Schober S, Hindupur S, Schoning C, Klein F, Mantwill K
Nat Commun. 2022; 13(1):4689.
PMID: 35948546
PMC: 9365808.
DOI: 10.1038/s41467-022-32087-5.
A Single Amino Acid Switch in the Adenoviral DNA Binding Protein Abrogates Replication Center Formation and Productive Viral Infection.
Boddin J, Ip W, Wilkens B, von Stromberg K, Ching W, Koyuncu E
mBio. 2022; 13(2):e0014422.
PMID: 35254132
PMC: 9040859.
DOI: 10.1128/mbio.00144-22.
E1B-55K Is a Phosphorylation-Dependent Transcriptional and Posttranscriptional Regulator of Viral Gene Expression in Human Adenovirus C5 Infection.
Hidalgo P, Garces Y, Mundo E, Lopez R, Bertzbach L, Dobner T
J Virol. 2022; 96(5):e0206221.
PMID: 35019711
PMC: 8906433.
DOI: 10.1128/jvi.02062-21.
Concepts in Oncolytic Adenovirus Therapy.
Mantwill K, Klein F, Wang D, Hindupur S, Ehrenfeld M, Holm P
Int J Mol Sci. 2021; 22(19).
PMID: 34638863
PMC: 8508870.
DOI: 10.3390/ijms221910522.
Potential Links between YB-1 and Fatty Acid Synthesis in Clear Cell Renal Carcinoma.
McCauley C, Anang V, Cole B, Simmons Jr G
Med Res Arch. 2021; 8(10).
PMID: 33778158
PMC: 7996393.
DOI: 10.18103/mra.v8i10.2273.
YB-1 Mediates TNF-Induced Pro-Survival Signaling by Regulating NF-κB Activation.
Shah A, Plaza-Sirvent C, Weinert S, Buchbinder J, Lavrik I, Mertens P
Cancers (Basel). 2020; 12(8).
PMID: 32764479
PMC: 7464034.
DOI: 10.3390/cancers12082188.
Y-Box Binding Proteins in mRNP Assembly, Translation, and Stability Control.
Mordovkina D, Lyabin D, Smolin E, Sogorina E, Ovchinnikov L, Eliseeva I
Biomolecules. 2020; 10(4).
PMID: 32290447
PMC: 7226217.
DOI: 10.3390/biom10040591.
Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation.
Taverner W, Jacobus E, Christianson J, Champion B, Paton A, Paton J
Mol Ther Oncolytics. 2020; 15:117-130.
PMID: 31890865
PMC: 6931121.
DOI: 10.1016/j.omto.2019.09.003.
Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells.
Czolk R, Schwarz N, Koch H, Schotterl S, Wuttke T, Holm P
Int J Mol Med. 2019; 44(4):1484-1494.
PMID: 31432139
PMC: 6713431.
DOI: 10.3892/ijmm.2019.4296.
Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.
Murugesan S, Yadav B, Maurya P, Chaudhary A, Singh S, Mani A
J Biosci. 2019; 44(2).
PMID: 31180040
Y-box-binding protein 1 supports the early and late steps of HIV replication.
Weydert C, van Heertum B, Dirix L, De Houwer S, De Wit F, Mast J
PLoS One. 2018; 13(7):e0200080.
PMID: 29995936
PMC: 6040738.
DOI: 10.1371/journal.pone.0200080.
Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma.
Murugesan S, Yadav B, Maurya P, Chaudhary A, Singh S, Mani A
J Genomics. 2018; 6:103-112.
PMID: 29973960
PMC: 6030768.
DOI: 10.7150/jgen.20581.
Investigation of function and regulation of the YB-1 cellular factor in HIV replication.
Jung Y, Yu K, Park S, Lee S, Kim M, You J
BMB Rep. 2018; 51(6):290-295.
PMID: 29429449
PMC: 6033064.
DOI: 10.5483/bmbrep.2018.51.6.231.
Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target.
Maurya P, Mishra A, Yadav B, Singh S, Kumar P, Chaudhary A
J Cancer. 2017; 8(10):1900-1907.
PMID: 28819388
PMC: 5556654.
DOI: 10.7150/jca.17689.
[YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?].
Holm P, Retz M, Gschwend J, Nawroth R
Urologe A. 2015; 55(3):356-63.
PMID: 26556269
DOI: 10.1007/s00120-015-3811-6.